Golden Arrow Merger Corp. Files Q1 2024 10-Q

Ticker: BSLKW · Form: 10-Q · Filed: May 20, 2024 · CIK: 1841125

Golden Arrow Merger Corp. 10-Q Filing Summary
FieldDetail
CompanyGolden Arrow Merger Corp. (BSLKW)
Form Type10-Q
Filed DateMay 20, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.0001, $11.50
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

Golden Arrow Merger Corp. filed its Q1 2024 10-Q. Check financials.

AI Summary

Golden Arrow Merger Corp. filed its quarterly report for the period ending March 31, 2024. The company, incorporated in Delaware, is involved in the industrial organic chemicals sector. Its principal executive offices are located at 10 E. 53rd Street, 13th Floor, New York, NY 10022.

Why It Matters

This filing provides investors with an update on Golden Arrow Merger Corp.'s financial performance and operational status for the first quarter of 2024.

Risk Assessment

Risk Level: low — This is a standard quarterly filing providing financial and operational updates, not indicating immediate significant risk.

Key Players & Entities

  • Golden Arrow Merger Corp. (company) — Registrant
  • March 31, 2024 (date) — End of reporting period
  • 10 E. 53rd Street, 13th Floor, New York, NY 10022 (location) — Principal executive offices
  • Delaware (location) — State of incorporation

FAQ

What is the primary business of Golden Arrow Merger Corp.?

Golden Arrow Merger Corp. is classified under the "INDUSTRIAL ORGANIC CHEMICALS" SIC code, specifically 2860.

For what period is this 10-Q report filed?

This report is for the quarter ended March 31, 2024.

Where are Golden Arrow Merger Corp.'s principal executive offices located?

The principal executive offices are located at 10 E. 53rd Street, 13th Floor, New York, NY 10022.

What is the company's state of incorporation?

The company is incorporated in Delaware.

What is the SEC file number for Golden Arrow Merger Corp.?

The SEC file number is 001-40223.

Filing Stats: 4,721 words · 19 min read · ~16 pages · Grade level 17.3 · Accepted 2024-05-20 16:49:44

Key Financial Figures

  • $0.0001 — et LLC Class A Common Stock, par value $0.0001 per share GAMC The Nasdaq Stock Market
  • $11.50 — A Common Stock at an exercise price of $11.50 GAMCW The Nasdaq Stock Market LLC Che

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Interim Financial Statements

Item 1. Interim Financial Statements. GOLDEN ARROW MERGER CORP. CONSOLIDATED CONDENSED BALANCE SHEETS March 31, December 31, 2024 2023 (unaudited) ASSETS Current Assets Cash $ 60,508 $ 306,034 Prepaid expenses 191,892 152,663 Total Current Assets 252,400 458,697 Cash held in Trust Account 6,271,861 6,218,429 Total Assets $ 6,524,261 $ 6,677,126 LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses $ 1,311,822 $ 1,135,140 Promissory note – related party 578,689 578,689 Convertible notes - related party 1,484,326 1,484,326 Excise tax payable 2,870,720 2,870,720 Income taxes payable 462,108 453,342 Total Current Liabilities 6,707,665 6,522,217 Deferred underwriting fee payable 10,062,500 10,062,500 Warrant liabilities 2,916,667 2,041,667 Total Liabilities 19,686,832 18,626,384 Commitments and Contingencies Class A common stock subject to possible redemption, $ 0.0001 par value, 200,000,000 shares authorized, 577,937 and 577,937 shares at a redemption value of $ 10.85 per share at March 31, 2024 and $ 10.76 per share at December 31, 2023, respectively 6,272,008 6,228,145 Stockholders' Deficit Preferred stock, $ 0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2024 and December 31, 2023 — — Class A common stock, $ 0.0001 par value; 200,000,000 shares authorized; 7,047,500 and 7,047,500 shares issued or outstanding (excluding 577,937 and 577,937 shares subject to possible redemption) at March 31, 2024 and December 31, 2023, respectively 705 705 Class B common stock, $ 0.0001 par value; 20,000,000 shares authorized; 140,000 shares issued and outstanding at March 31, 2024 and December 31, 2023 14 14 Additional paid-in capital — — Accumulated deficit ( 19,435,298 ) ( 18,178,122 ) Total Stockholders' Deficit ( 19,434,579 ) ( 18,177,403 )

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.